Marc Girard

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Marc Girard, Pierre Duquette, W. A. Sibley · 1993 · 1.2K citations

Clinical Results, Relapsing-remitting Multiple Sclerosis, Neurological Disorder +10

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 511 citations · Full text

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 401 citations · Full text

Neurological Disorder, Disability, Clinical Neurology +22

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 401 citations · Full text

Disease Progression, Neurological Disorder, Clinical Epidemiology +7

Defining reliable disability outcomes in multiple sclerosis

Tomáš Kalinčík, Gary Cutter, Tim Spelman et al. · Brain · 2015 · 223 citations · Full text